GE HEALTHCARE TECHNOLOGIES INC.

NASDAQ: GEHC (GE HealthCare Technologies Inc.)

Last update: 8 hours ago

84.03

-0.02 (-0.02%)

Previous Close 84.05
Open 84.16
Volume 2,097,794
Avg. Volume (3M) 3,432,503
Market Cap 38,296,653,824
Price / Earnings (TTM) 18.47
Price / Earnings (Forward) 16.69
Price / Sales 1.77
Price / Book 3.61
52 Weeks Range
57.65 (-31%) — 92.20 (9%)
Earnings Date 29 Apr 2026
TTM Dividend Yield 0.17%
Profit Margin 11.03%
Operating Margin (TTM) 14.78%
Diluted EPS (TTM) 4.76
Quarterly Revenue Growth (YOY) 2.70%
Quarterly Earnings Growth (YOY) 50.80%
Total Debt/Equity (MRQ) 97.51%
Current Ratio (MRQ) 0.980
Operating Cash Flow (TTM) 1.78 B
Levered Free Cash Flow (TTM) 1.58 B
Return on Assets (TTM) 5.87%
Return on Equity (TTM) 26.44%

Market Trend

Short Term Medium Term
Industry Health Information Services (US) Mixed Bearish
Health Information Services (Global) Mixed Bearish
Stock GE HealthCare Technologies Inc. Bullish Bearish

AIStockmoo Score

0.8
Analyst Consensus 1.5
Insider Activity 0.0
Price Volatility -0.5
Technical Moving Averages -1.0
Technical Oscillators 4.0
Average 0.80

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
GEHC 38 B 0.17% 18.47 3.61
TEM 9 B - - 50.12
BTSG 7 B - 69.98 2.92
HQY 6 B - 34.04 3.60
RCM 6 B - - 2.14
WAY 5 B - 38.94 1.59

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (54% of revenue), ultrasound (18%), patient care solutions (16%), and pharmaceutical diagnostics (12%). The company’s sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 44%, 26%, 14%, and 16% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (33% of revenue), pharmaceutical diagnostics (12%), and digital solutions (6%).

Sector Healthcare
Industry Health Information Services
Investment Style Mid Core
% Held by Insiders 0.28%
% Held by Institutions 80.26%

Ownership

Name Date Shares Held
Harris Associates L P 31 Dec 2025 15,854,646
Hotchkis & Wiley Capital Management Llc 31 Dec 2025 9,032,745
Barrow Hanley Mewhinney & Strauss Llc 31 Dec 2025 6,506,398
52 Weeks Range
57.65 (-31%) — 92.20 (9%)
Price Target Range
77.00 (-8%) — 105.00 (24%)
High 105.00 (Jefferies, 24.96%) Buy
Median 92.00 (9.49%)
Low 77.00 (UBS, -8.37%) Sell
Average 92.00 (9.49%)
Total 6 Buy, 4 Hold, 1 Sell
Avg. Price @ Call 82.51
Firm Date Target Price Call Price @ Call
BTIG 09 Feb 2026 91.00 (8.29%) Buy 79.08
04 Feb 2026 91.00 (8.29%) Buy 82.63
Barclays 06 Feb 2026 87.00 (3.53%) Hold 80.65
Evercore ISI Group 05 Feb 2026 98.00 (16.63%) Buy 82.31
Morgan Stanley 05 Feb 2026 85.00 (1.15%) Hold 82.31
Stifel 05 Feb 2026 98.00 (16.63%) Buy 82.31
07 Jan 2026 95.00 (13.05%) Buy 85.76
Wells Fargo 05 Feb 2026 97.00 (15.43%) Buy 82.31
Piper Sandler 30 Jan 2026 94.00 (11.86%) Buy 78.97
UBS 15 Jan 2026 77.00 (-8.37%) Sell 82.51
B of A Securities 05 Jan 2026 92.00 (9.48%) Hold 85.04
Citigroup 11 Dec 2025 88.00 (4.72%) Hold 86.05
Jefferies 11 Dec 2025 105.00 (24.96%) Buy 86.05
Show more
Name Avg. Buy ($) Avg. Sell ($) Net Quantity Net Value ($)
ARDUINI PETER J 78.65 78.65 41,463 3,261,065
JIMENEZ FRANK R 78.65 78.65 13,721 1,079,157
KASS-HOUT TAHA 78.65 78.65 15,552 1,223,165
NEWCOMB GEORGE A. 78.65 78.65 1,721 135,357
O'NEILL KEVIN MICHAEL 78.65 78.65 3,677 289,196
RACKLIFFE PHILIP 78.65 78.65 1,980 155,727
ROTT ROLAND 78.65 78.65 3,942 310,038
SACCARO JAMES 78.65 78.65 14,040 1,104,246
Aggregate Net Quantity 96,096
Aggregate Net Value ($) 7,557,950
Aggregate Avg. Buy ($) 78.65
Aggregate Avg. Sell ($) 78.65
Name Holder Date Type Quantity Price Value ($)
ARDUINI PETER J Officer 12 Feb 2026 Acquired (+) 74,908 78.65 5,891,514
ARDUINI PETER J Officer 12 Feb 2026 Disposed (-) 33,445 78.65 2,630,449
SACCARO JAMES Officer 12 Feb 2026 Acquired (+) 22,610 78.65 1,778,277
SACCARO JAMES Officer 12 Feb 2026 Disposed (-) 8,570 78.65 674,031
JIMENEZ FRANK R Officer 12 Feb 2026 Acquired (+) 22,078 78.65 1,736,435
JIMENEZ FRANK R Officer 12 Feb 2026 Disposed (-) 8,357 78.65 657,278
KASS-HOUT TAHA Officer 12 Feb 2026 Acquired (+) 23,339 78.65 1,835,612
KASS-HOUT TAHA Officer 12 Feb 2026 Disposed (-) 7,787 78.65 612,448
ROTT ROLAND Officer 12 Feb 2026 Acquired (+) 7,885 78.65 620,155
ROTT ROLAND Officer 12 Feb 2026 Disposed (-) 3,943 78.65 310,117
RACKLIFFE PHILIP Officer 12 Feb 2026 Acquired (+) 3,154 78.65 248,062
RACKLIFFE PHILIP Officer 12 Feb 2026 Disposed (-) 1,174 78.65 92,335
O'NEILL KEVIN MICHAEL Officer 12 Feb 2026 Acquired (+) 6,938 78.65 545,674
O'NEILL KEVIN MICHAEL Officer 12 Feb 2026 Disposed (-) 3,261 78.65 256,478
NEWCOMB GEORGE A. Officer 12 Feb 2026 Acquired (+) 2,523 78.65 198,434
NEWCOMB GEORGE A. Officer 12 Feb 2026 Disposed (-) 802 78.65 63,077
Show more
Date Type Details
04 Feb 2026 Announcement GE HealthCare reports fourth quarter and full year 2025 financial results
02 Feb 2026 Announcement GE HealthCare announces U.S. FDA 510(k) clearance and CE Mark for Allia Moveo and marks first global installation, advancing precision care in the interventional suite
06 Jan 2026 Announcement GE HealthCare Recommends Shareholders Reject “Mini-Tender” Offer by Potemkin Limited
06 Jan 2026 Announcement NXP and GE HealthCare Accelerate AI Innovation in Acute Care
05 Jan 2026 Announcement GE HealthCare to announce fourth quarter and full year 2025 results on February 4, 2026
29 Dec 2025 Announcement GE HealthCare management to present at upcoming investor conference
16 Dec 2025 Announcement GE HealthCare and Indonesia’s Ministry of Health to expand access to quality care through the provision of 300+ advanced CT scanners
03 Dec 2025 Announcement GE HealthCare and Mayo Clinic unveil GEMINI-RT: A bold research collaboration in radiation therapy and advanced cancer care
03 Dec 2025 Announcement University of Rochester Medical Center and GE HealthCare form seven-year Care Alliance to build advanced capabilities across system
02 Dec 2025 Announcement GE HealthCare introduces advanced imaging solutions powered by NVIDIA technology to support timely diagnoses and streamlined clinical workflows
01 Dec 2025 Announcement GE HealthCare unveils Allia Moveo, designed to deliver next-level mobility, workflow and comfort in the interventional suite
30 Nov 2025 Announcement GE HealthCare builds on a century of innovation to shape the future of radiology at RSNA 2025
30 Nov 2025 Announcement GE HealthCare unveils next-generation SIGNA MRI technology, aiming to boost efficiency, enhance patient experience, and advance sustainability
26 Nov 2025 Announcement GE HealthCare unveils Pristina Recon DL for mammography – deep learning image reconstruction technology delivering clearer image quality
Show more
TTM Dividend Yield 0.17%
3Y Average Dividend Yield 0.15%
Payout Ratio 2.63%
Expected Next Dividend Payment Aug 2026
Ex Date Announcement Date Payment Date Details
02 Apr 2026 12 Feb 2026 15 May 2026 0.035 Cash
09 Jan 2026 24 Nov 2025 13 Feb 2026 0.035 Cash
24 Oct 2025 24 Sep 2025 14 Nov 2025 0.035 Cash
25 Jul 2025 01 Jul 2025 15 Aug 2025 0.035 Cash
25 Apr 2025 27 Mar 2025 15 May 2025 0.035 Cash
14 Jan 2025 21 Nov 2024 14 Feb 2025 0.035 Cash
18 Oct 2024 18 Sep 2024 15 Nov 2024 0.03 Cash
19 Jul 2024 26 Jun 2024 15 Aug 2024 0.03 Cash
18 Apr 2024 22 Mar 2024 15 May 2024 0.03 Cash
12 Jan 2024 08 Dec 2023 15 Feb 2024 0.03 Cash
19 Oct 2023 22 Sep 2023 15 Nov 2023 0.03 Cash
20 Jul 2023 23 Jun 2023 15 Aug 2023 0.03 Cash
22 May 2023 25 Apr 2023 15 Jun 2023 0.03 Cash
Show more

Annual Dividend Yield

Year Annual Dividend ($) Frequency/Year Yield %
2026 0.070 2 0.08
2025 0.140 4 0.17
2024 0.120 4 0.15
2023 0.090 3 0.12

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria